P J Lansberg
Overview
Explore the profile of P J Lansberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balder J, Lansberg P, Hof M, Wiegman A, Hutten B, Kuivenhoven J
J Clin Lipidol
. 2018 Jul;
12(5):1208-1216.
PMID: 30007775
Background: Atherosclerosis starts in childhood and its progression is influenced by lifelong low-density lipoprotein cholesterol (LDL-c) exposure, the so-called cholesterol burden. Early identification of children and adolescents with severely elevated...
2.
Jukema J, Lansberg P
Neth Heart J
. 2015 Feb;
9(8):343-345.
PMID: 25696757
Looking at the world today and six months ago in retrospect, it becomes clear that things have changed dramatically. Not only are global economic forecasts in turmoil, other certainties have...
3.
Brunham L, Lansberg P, Zhang L, Miao F, Carter C, Hovingh G, et al.
Pharmacogenomics J
. 2011 Jan;
12(3):233-7.
PMID: 21243006
Statins reduce cardiovascular morbidity and mortality in appropriately selected patients. However, statin-associated myopathy is a significant risk associated with these agents. Recently, variation in the SLCO1B1 gene was reported to...
4.
Jansen A, van Aalst-Cohen E, Tanck M, Trip M, Lansberg P, Liem A, et al.
J Intern Med
. 2004 Nov;
256(6):482-90.
PMID: 15554949
Objective: To determine the contribution of classical risk factors to the development of cardiovascular disease (CVD) in patients with heterozygous familial hypercholesterolaemia (FH). Design: A retrospective, multi-centre, cohort study. Extensive...
5.
Homsma S, Lansberg P, Kastelein J
Ned Tijdschr Geneeskd
. 2004 Mar;
148(10):493-6.
PMID: 15042898
In the Netherlands, people with familial hypercholesterolaemia (FH) have been actively screened since 1994 by means of DNA analysis. Recently, the Stichting Opsporing Erfelijke Hypercholesterolemie (Foundation for the Detection of...
6.
de Sauvage Nolting P, Defesche J, Buirma R, Hutten B, Lansberg P, Kastelein J
J Intern Med
. 2003 Jan;
253(2):161-8.
PMID: 12542556
Objective: Patients with familial hypercholesterolaemia (FH) vary widely in terms of onset of cardiovascular disease (CVD). Design: The association between cardiovascular risk factors and prevalent CVD was examined in a...
7.
Van Dam M, Zwart M, de Beer F, Smelt A, Prins M, Trip M, et al.
Heart
. 2002 Aug;
88(3):234-8.
PMID: 12181212
Background: Fibric acid derivatives and HMG-CoA reductase inhibitors are effective in combination for treating patients with familial dysbetalipoproteinaemia and severe combined dyslipidaemia, but combination therapy affects compliance and increases the...
8.
Lansberg P, Tuzgol S, van de Ree M, Defesche J, Kastelein J
Ned Tijdschr Geneeskd
. 2000 Aug;
144(30):1437-40.
PMID: 10932696
Objective: To determine the prevalence of familial hypercholesterolaemia (FH). Design: Patient record screening, questionnaire and if necessary, case finding. Methods: Over the period mid-1990-mid-1992 (approximately 2.5 years) 8,800 adult individuals...
9.
Trip M, Lansberg P, de Jongh S, Kastelein J
Ned Tijdschr Geneeskd
. 2000 Aug;
144(30):1425-8.
PMID: 10932693
A man aged 35 and a woman aged 30 visited a lipid clinic because of a raised total cholesterol level, which was also present in a number of first-degree relatives....
10.
Visseren F, Lansberg P, Erkelens D, Kastelein J
Ned Tijdschr Geneeskd
. 2000 May;
144(17):822-3.
PMID: 10800556
No abstract available.